2013
DOI: 10.1590/s0004-27302013000400010
|View full text |Cite
|
Sign up to set email alerts
|

Errata

Abstract: Arq Bras Endocrinol Metab. 2013;57(2):89-97 Figure 3. Negative predictive value (NPV) of Afirma (20) and a Mutational Panel (38) according to the prevalence of malignancy.Figure 3. Negative predictive value (NPV) of Afirma (20) and a Mutational Panel (38) according to the prevalence of malignancy.Leia-se: 100% 95% 90% 85% 80% 10% 15% 89% 94% 95% 97% 20% 25% 30% Prevalence (risk) of malignancy Atypia/FLUS NPV A rma NPV Mutational Panel NPV 1. 1. 1. 1. 1. 0. 0. 89% 94% 95% 97% 0. 0. 0. Prevalence (risk) of malig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance